ArticleFrontiers in pharmacology2026

Efficacy and safety of Nefecon, glucocorticoids, or supportive therapyadded to RASi+SGLT2i in IgA nephropathy.

Tiantian Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.